Covid-19 Impact on Global Newborn and Prenatal Genetic Testing Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 06-May-2020
No. of pages: 96
Inquire Before Buying

This report focuses on the global Newborn and Prenatal Genetic Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Newborn and Prenatal Genetic Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Perkin Elmer

- Verinata Health

- Sequenom, Inc.

- Agilent Technologies, Inc.

- Bio-Rad Laboratories, Inc.

- Natera, Inc.

- Illumina, Inc.

- Ariosa Diagnostics

- BGI

- CapitalBio MedLab

Market segment by Type, the product can be split into

- PCR

- FISH

- aCGH

- NIPT

- MSS

Market segment by Application, split into

- Hospital

- Clinic

- Others

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Newborn and Prenatal Genetic Testing status, future forecast, growth opportunity, key market and key players.

- To present the Newborn and Prenatal Genetic Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Newborn and Prenatal Genetic Testing are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Covid-19 Impact on Global Newborn and Prenatal Genetic Testing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Newborn and Prenatal Genetic Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Newborn and Prenatal Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 PCR
1.4.3 FISH
1.4.4 aCGH
1.4.5 NIPT
1.4.6 MSS
1.5 Market by Application
1.5.1 Global Newborn and Prenatal Genetic Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Newborn and Prenatal Genetic Testing Industry Impact
1.6.1 How the Covid-19 is Affecting the Newborn and Prenatal Genetic Testing Industry
1.6.1.1 Newborn and Prenatal Genetic Testing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Newborn and Prenatal Genetic Testing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Newborn and Prenatal Genetic Testing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Newborn and Prenatal Genetic Testing Market Perspective (2015-2026)
2.2 Newborn and Prenatal Genetic Testing Growth Trends by Regions
2.2.1 Newborn and Prenatal Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Newborn and Prenatal Genetic Testing Historic Market Share by Regions (2015-2020)
2.2.3 Newborn and Prenatal Genetic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Newborn and Prenatal Genetic Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Newborn and Prenatal Genetic Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Newborn and Prenatal Genetic Testing Players by Market Size
3.1.1 Global Top Newborn and Prenatal Genetic Testing Players by Revenue (2015-2020)
3.1.2 Global Newborn and Prenatal Genetic Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Newborn and Prenatal Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Newborn and Prenatal Genetic Testing Market Concentration Ratio
3.2.1 Global Newborn and Prenatal Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Newborn and Prenatal Genetic Testing Revenue in 2019
3.3 Newborn and Prenatal Genetic Testing Key Players Head office and Area Served
3.4 Key Players Newborn and Prenatal Genetic Testing Product Solution and Service
3.5 Date of Enter into Newborn and Prenatal Genetic Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Newborn and Prenatal Genetic Testing Historic Market Size by Type (2015-2020)
4.2 Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Type (2021-2026)
5 Newborn and Prenatal Genetic Testing Breakdown Data by Application (2015-2026)
5.1 Global Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020)
5.2 Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Newborn and Prenatal Genetic Testing Market Size (2015-2020)
6.2 Newborn and Prenatal Genetic Testing Key Players in North America (2019-2020)
6.3 North America Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020)
6.4 North America Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Newborn and Prenatal Genetic Testing Market Size (2015-2020)
7.2 Newborn and Prenatal Genetic Testing Key Players in Europe (2019-2020)
7.3 Europe Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020)
7.4 Europe Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020)
8 China
8.1 China Newborn and Prenatal Genetic Testing Market Size (2015-2020)
8.2 Newborn and Prenatal Genetic Testing Key Players in China (2019-2020)
8.3 China Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020)
8.4 China Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Newborn and Prenatal Genetic Testing Market Size (2015-2020)
9.2 Newborn and Prenatal Genetic Testing Key Players in Japan (2019-2020)
9.3 Japan Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020)
9.4 Japan Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Newborn and Prenatal Genetic Testing Market Size (2015-2020)
10.2 Newborn and Prenatal Genetic Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020)
11 India
11.1 India Newborn and Prenatal Genetic Testing Market Size (2015-2020)
11.2 Newborn and Prenatal Genetic Testing Key Players in India (2019-2020)
11.3 India Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020)
11.4 India Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Newborn and Prenatal Genetic Testing Market Size (2015-2020)
12.2 Newborn and Prenatal Genetic Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020)
12.4 Central & South America Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Perkin Elmer
13.1.1 Perkin Elmer Company Details
13.1.2 Perkin Elmer Business Overview and Its Total Revenue
13.1.3 Perkin Elmer Newborn and Prenatal Genetic Testing Introduction
13.1.4 Perkin Elmer Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020))
13.1.5 Perkin Elmer Recent Development
13.2 Verinata Health
13.2.1 Verinata Health Company Details
13.2.2 Verinata Health Business Overview and Its Total Revenue
13.2.3 Verinata Health Newborn and Prenatal Genetic Testing Introduction
13.2.4 Verinata Health Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.2.5 Verinata Health Recent Development
13.3 Sequenom, Inc.
13.3.1 Sequenom, Inc. Company Details
13.3.2 Sequenom, Inc. Business Overview and Its Total Revenue
13.3.3 Sequenom, Inc. Newborn and Prenatal Genetic Testing Introduction
13.3.4 Sequenom, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.3.5 Sequenom, Inc. Recent Development
13.4 Agilent Technologies, Inc.
13.4.1 Agilent Technologies, Inc. Company Details
13.4.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue
13.4.3 Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Introduction
13.4.4 Agilent Technologies, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.4.5 Agilent Technologies, Inc. Recent Development
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Bio-Rad Laboratories, Inc. Company Details
13.5.2 Bio-Rad Laboratories, Inc. Business Overview and Its Total Revenue
13.5.3 Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Introduction
13.5.4 Bio-Rad Laboratories, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.5.5 Bio-Rad Laboratories, Inc. Recent Development
13.6 Natera, Inc.
13.6.1 Natera, Inc. Company Details
13.6.2 Natera, Inc. Business Overview and Its Total Revenue
13.6.3 Natera, Inc. Newborn and Prenatal Genetic Testing Introduction
13.6.4 Natera, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.6.5 Natera, Inc. Recent Development
13.7 Illumina, Inc.
13.7.1 Illumina, Inc. Company Details
13.7.2 Illumina, Inc. Business Overview and Its Total Revenue
13.7.3 Illumina, Inc. Newborn and Prenatal Genetic Testing Introduction
13.7.4 Illumina, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.7.5 Illumina, Inc. Recent Development
13.8 Ariosa Diagnostics
13.8.1 Ariosa Diagnostics Company Details
13.8.2 Ariosa Diagnostics Business Overview and Its Total Revenue
13.8.3 Ariosa Diagnostics Newborn and Prenatal Genetic Testing Introduction
13.8.4 Ariosa Diagnostics Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.8.5 Ariosa Diagnostics Recent Development
13.9 BGI
13.9.1 BGI Company Details
13.9.2 BGI Business Overview and Its Total Revenue
13.9.3 BGI Newborn and Prenatal Genetic Testing Introduction
13.9.4 BGI Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.9.5 BGI Recent Development
13.10 CapitalBio MedLab
13.10.1 CapitalBio MedLab Company Details
13.10.2 CapitalBio MedLab Business Overview and Its Total Revenue
13.10.3 CapitalBio MedLab Newborn and Prenatal Genetic Testing Introduction
13.10.4 CapitalBio MedLab Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020)
13.10.5 CapitalBio MedLab Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Newborn and Prenatal Genetic Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Newborn and Prenatal Genetic Testing Revenue
Table 3. Ranking of Global Top Newborn and Prenatal Genetic Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Newborn and Prenatal Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PCR
Table 6. Key Players of FISH
Table 7. Key Players of aCGH
Table 8. Key Players of NIPT
Table 9. Key Players of MSS
Table 10. COVID-19 Impact Global Market: (Four Newborn and Prenatal Genetic Testing Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Newborn and Prenatal Genetic Testing Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Newborn and Prenatal Genetic Testing Players to Combat Covid-19 Impact
Table 15. Global Newborn and Prenatal Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Newborn and Prenatal Genetic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Newborn and Prenatal Genetic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Newborn and Prenatal Genetic Testing Market Share by Regions (2015-2020)
Table 19. Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Newborn and Prenatal Genetic Testing Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Newborn and Prenatal Genetic Testing Market Growth Strategy
Table 25. Main Points Interviewed from Key Newborn and Prenatal Genetic Testing Players
Table 26. Global Newborn and Prenatal Genetic Testing Revenue by Players (2015-2020) (Million US$)
Table 27. Global Newborn and Prenatal Genetic Testing Market Share by Players (2015-2020)
Table 28. Global Top Newborn and Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Newborn and Prenatal Genetic Testing as of 2019)
Table 29. Global Newborn and Prenatal Genetic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Newborn and Prenatal Genetic Testing Product Solution and Service
Table 32. Date of Enter into Newborn and Prenatal Genetic Testing Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 35. Global Newborn and Prenatal Genetic Testing Market Size Share by Type (2015-2020)
Table 36. Global Newborn and Prenatal Genetic Testing Revenue Market Share by Type (2021-2026)
Table 37. Global Newborn and Prenatal Genetic Testing Market Size Share by Application (2015-2020)
Table 38. Global Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 39. Global Newborn and Prenatal Genetic Testing Market Size Share by Application (2021-2026)
Table 40. North America Key Players Newborn and Prenatal Genetic Testing Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Newborn and Prenatal Genetic Testing Market Share (2019-2020)
Table 42. North America Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 43. North America Newborn and Prenatal Genetic Testing Market Share by Type (2015-2020)
Table 44. North America Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 45. North America Newborn and Prenatal Genetic Testing Market Share by Application (2015-2020)
Table 46. Europe Key Players Newborn and Prenatal Genetic Testing Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Newborn and Prenatal Genetic Testing Market Share (2019-2020)
Table 48. Europe Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Newborn and Prenatal Genetic Testing Market Share by Type (2015-2020)
Table 50. Europe Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Newborn and Prenatal Genetic Testing Market Share by Application (2015-2020)
Table 52. China Key Players Newborn and Prenatal Genetic Testing Revenue (2019-2020) (Million US$)
Table 53. China Key Players Newborn and Prenatal Genetic Testing Market Share (2019-2020)
Table 54. China Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 55. China Newborn and Prenatal Genetic Testing Market Share by Type (2015-2020)
Table 56. China Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 57. China Newborn and Prenatal Genetic Testing Market Share by Application (2015-2020)
Table 58. Japan Key Players Newborn and Prenatal Genetic Testing Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Newborn and Prenatal Genetic Testing Market Share (2019-2020)
Table 60. Japan Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Newborn and Prenatal Genetic Testing Market Share by Type (2015-2020)
Table 62. Japan Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Newborn and Prenatal Genetic Testing Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Newborn and Prenatal Genetic Testing Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Newborn and Prenatal Genetic Testing Market Share (2019-2020)
Table 66. Southeast Asia Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Newborn and Prenatal Genetic Testing Market Share by Type (2015-2020)
Table 68. Southeast Asia Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Newborn and Prenatal Genetic Testing Market Share by Application (2015-2020)
Table 70. India Key Players Newborn and Prenatal Genetic Testing Revenue (2019-2020) (Million US$)
Table 71. India Key Players Newborn and Prenatal Genetic Testing Market Share (2019-2020)
Table 72. India Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 73. India Newborn and Prenatal Genetic Testing Market Share by Type (2015-2020)
Table 74. India Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 75. India Newborn and Prenatal Genetic Testing Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Newborn and Prenatal Genetic Testing Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Newborn and Prenatal Genetic Testing Market Share (2019-2020)
Table 78. Central & South America Newborn and Prenatal Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Newborn and Prenatal Genetic Testing Market Share by Type (2015-2020)
Table 80. Central & South America Newborn and Prenatal Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Newborn and Prenatal Genetic Testing Market Share by Application (2015-2020)
Table 82. Perkin Elmer Company Details
Table 83. Perkin Elmer Business Overview
Table 84. Perkin Elmer Product
Table 85. Perkin Elmer Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 86. Perkin Elmer Recent Development
Table 87. Verinata Health Company Details
Table 88. Verinata Health Business Overview
Table 89. Verinata Health Product
Table 90. Verinata Health Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 91. Verinata Health Recent Development
Table 92. Sequenom, Inc. Company Details
Table 93. Sequenom, Inc. Business Overview
Table 94. Sequenom, Inc. Product
Table 95. Sequenom, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 96. Sequenom, Inc. Recent Development
Table 97. Agilent Technologies, Inc. Company Details
Table 98. Agilent Technologies, Inc. Business Overview
Table 99. Agilent Technologies, Inc. Product
Table 100. Agilent Technologies, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 101. Agilent Technologies, Inc. Recent Development
Table 102. Bio-Rad Laboratories, Inc. Company Details
Table 103. Bio-Rad Laboratories, Inc. Business Overview
Table 104. Bio-Rad Laboratories, Inc. Product
Table 105. Bio-Rad Laboratories, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 106. Bio-Rad Laboratories, Inc. Recent Development
Table 107. Natera, Inc. Company Details
Table 108. Natera, Inc. Business Overview
Table 109. Natera, Inc. Product
Table 110. Natera, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 111. Natera, Inc. Recent Development
Table 112. Illumina, Inc. Company Details
Table 113. Illumina, Inc. Business Overview
Table 114. Illumina, Inc. Product
Table 115. Illumina, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 116. Illumina, Inc. Recent Development
Table 117. Ariosa Diagnostics Business Overview
Table 118. Ariosa Diagnostics Product
Table 119. Ariosa Diagnostics Company Details
Table 120. Ariosa Diagnostics Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 121. Ariosa Diagnostics Recent Development
Table 122. BGI Company Details
Table 123. BGI Business Overview
Table 124. BGI Product
Table 125. BGI Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 126. BGI Recent Development
Table 127. CapitalBio MedLab Company Details
Table 128. CapitalBio MedLab Business Overview
Table 129. CapitalBio MedLab Product
Table 130. CapitalBio MedLab Revenue in Newborn and Prenatal Genetic Testing Business (2015-2020) (Million US$)
Table 131. CapitalBio MedLab Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Newborn and Prenatal Genetic Testing Market Share by Type: 2020 VS 2026
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. aCGH Features
Figure 5. NIPT Features
Figure 6. MSS Features
Figure 7. Global Newborn and Prenatal Genetic Testing Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Newborn and Prenatal Genetic Testing Report Years Considered
Figure 12. Global Newborn and Prenatal Genetic Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Newborn and Prenatal Genetic Testing Market Share by Regions: 2020 VS 2026
Figure 14. Global Newborn and Prenatal Genetic Testing Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Newborn and Prenatal Genetic Testing Market Share by Players in 2019
Figure 17. Global Top Newborn and Prenatal Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Newborn and Prenatal Genetic Testing as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Newborn and Prenatal Genetic Testing Revenue in 2019
Figure 19. North America Newborn and Prenatal Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Newborn and Prenatal Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Newborn and Prenatal Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Newborn and Prenatal Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Newborn and Prenatal Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Newborn and Prenatal Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Newborn and Prenatal Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Perkin Elmer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Perkin Elmer Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 28. Verinata Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Verinata Health Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 30. Sequenom, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Sequenom, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 32. Agilent Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Agilent Technologies, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 34. Bio-Rad Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 36. Natera, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Natera, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 38. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Illumina, Inc. Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 40. Ariosa Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Ariosa Diagnostics Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 42. BGI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. BGI Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 44. CapitalBio MedLab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. CapitalBio MedLab Revenue Growth Rate in Newborn and Prenatal Genetic Testing Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs